10 USD
+0.08 (+0.81%)
9.99 USD
-0.01 (-0.1%)
Taking everything into account, APEN scores 1 out of 10 in our fundamental rating. APEN was compared to 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of APEN have multiple concerns. APEN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year APEN has reported negative net income.
- In the past year APEN has reported a negative cash flow from operations.
1.2 Ratios
- The profitability ratios for APEN are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- APEN has a Gross Margin (55.20%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of APEN has declined.
- APEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.92%
GM growth 5Y-2.23%
2. Health
2.1 Basic Checks
- APEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- APEN has more shares outstanding than it did 1 year ago.
- Compared to 1 year ago, APEN has a worse debt to assets ratio.
2.2 Solvency
- APEN has an Altman-Z score of -0.16. This is a bad value and indicates that APEN is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of APEN (-0.16) is worse than 60.56% of its industry peers.
- APEN has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.04, APEN is not doing good in the industry: 79.34% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.16 |
ROIC/WACCN/A
WACC10.2%
2.3 Liquidity
- APEN has a Current Ratio of 2.35. This indicates that APEN is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.35, APEN is doing worse than 66.20% of the companies in the same industry.
- APEN has a Quick Ratio of 1.89. This is a normal value and indicates that APEN is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.89, APEN is doing worse than 60.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
- APEN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.99%.
- The Revenue has grown by 22.01% in the past year. This is a very strong growth!
- The Revenue has been growing slightly by 3.63% on average over the past years.
EPS 1Y (TTM)-9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.21%
Revenue 1Y (TTM)22.01%
Revenue growth 3Y14.87%
Revenue growth 5Y3.63%
Sales Q2Q%31.8%
3.2 Future
- The Earnings Per Share is expected to grow by 11.79% on average over the next years. This is quite good.
- Based on estimates for the next years, APEN will show a very strong growth in Revenue. The Revenue will grow by 33.84% on average per year.
EPS Next Y13.1%
EPS Next 2Y11.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.29%
Revenue Next 2Y20.22%
Revenue Next 3Y33.84%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- APEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year APEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.79%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- APEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
APOLLO ENDOSURGERY INC / APEN FAQ
Can you provide the ChartMill fundamental rating for APOLLO ENDOSURGERY INC?
ChartMill assigns a fundamental rating of 2 / 10 to APEN.
What is the valuation status of APOLLO ENDOSURGERY INC (APEN) stock?
ChartMill assigns a valuation rating of 0 / 10 to APOLLO ENDOSURGERY INC (APEN). This can be considered as Overvalued.
How profitable is APOLLO ENDOSURGERY INC (APEN) stock?
APOLLO ENDOSURGERY INC (APEN) has a profitability rating of 1 / 10.
How financially healthy is APOLLO ENDOSURGERY INC?
The financial health rating of APOLLO ENDOSURGERY INC (APEN) is 2 / 10.
What is the earnings growth outlook for APOLLO ENDOSURGERY INC?
The Earnings per Share (EPS) of APOLLO ENDOSURGERY INC (APEN) is expected to grow by 13.1% in the next year.